
### [MONDO:0018373](http://purl.obolibrary.org/obo/MONDO_0018373)
**Label:** avascular necrosis

**Subclasses:** [MONDO:0013144](http://purl.obolibrary.org/obo/MONDO_0013144) (antithrombin III deficiency), [MONDO:0011382](http://purl.obolibrary.org/obo/MONDO_0011382) (sickle cell anemia), [MONDO:0016320](http://purl.obolibrary.org/obo/MONDO_0016320) (rare hereditary thrombophilia), [MONDO:0018378](http://purl.obolibrary.org/obo/MONDO_0018378) (osteonecrosis of the jaw), [MONDO:0018379](http://purl.obolibrary.org/obo/MONDO_0018379) (primary avascular necrosis), [MONDO:0009265](http://purl.obolibrary.org/obo/MONDO_0009265) (Gaucher's disease type I), [MONDO:0012860](http://purl.obolibrary.org/obo/MONDO_0012860) (thrombophilia due to protein C deficiency, autosomal recessive), [MONDO:0018376](http://purl.obolibrary.org/obo/MONDO_0018376) (secondary non-traumatic avascular necrosis), [MONDO:0013791](http://purl.obolibrary.org/obo/MONDO_0013791) (thrombophilia due to protein S deficiency, autosomal recessive), [MONDO:0009267](http://purl.obolibrary.org/obo/MONDO_0009267) (Gaucher's disease type III), [MONDO:0018377](http://purl.obolibrary.org/obo/MONDO_0018377) (rare hereditary disease with avascular necrosis), [MONDO:0013143](http://purl.obolibrary.org/obo/MONDO_0013143) (hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency), [MONDO:0019144](http://purl.obolibrary.org/obo/MONDO_0019144) (hereditary thrombophilia due to congenital protein S deficiency), [MONDO:0018374](http://purl.obolibrary.org/obo/MONDO_0018374) (secondary avascular necrosis), [MONDO:0018375](http://purl.obolibrary.org/obo/MONDO_0018375) (traumatic avascular necrosis), [MONDO:0019145](http://purl.obolibrary.org/obo/MONDO_0019145) (hereditary thrombophilia due to congenital protein C deficiency), [MONDO:0018384](http://purl.obolibrary.org/obo/MONDO_0018384) (avascular necrosis of genetic origin), [MONDO:0008316](http://purl.obolibrary.org/obo/MONDO_0008316) (thrombophilia due to protein C deficiency, autosomal dominant), [MONDO:0018380](http://purl.obolibrary.org/obo/MONDO_0018380) (idiopathic avascular necrosis), [MONDO:0012126](http://purl.obolibrary.org/obo/MONDO_0012126) (familial avascular necrosis of femoral head), [MONDO:0012868](http://purl.obolibrary.org/obo/MONDO_0012868) (thrombophilia due to protein S deficiency, autosomal dominant), [MONDO:0012911](http://purl.obolibrary.org/obo/MONDO_0012911) (pseudohypoparathyroidism type 1C), 

**Mapped go classes:** [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0006680](http://purl.obolibrary.org/obo/GO_0006680) (glucosylceramide catabolic process), [GO:0015671](http://purl.obolibrary.org/obo/GO_0015671) (oxygen transport), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:1904457](http://purl.obolibrary.org/obo/GO_1904457) (positive regulation of neuronal action potential), [GO:0043589](http://purl.obolibrary.org/obo/GO_0043589) (skin morphogenesis), [GO:0043621](http://purl.obolibrary.org/obo/GO_0043621) (protein self-association), [GO:0051246](http://purl.obolibrary.org/obo/GO_0051246) (regulation of protein metabolic process), [GO:0051247](http://purl.obolibrary.org/obo/GO_0051247) (positive regulation of protein metabolic process), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0030308](http://purl.obolibrary.org/obo/GO_0030308) (negative regulation of cell growth), [GO:0071773](http://purl.obolibrary.org/obo/GO_0071773) (cellular response to BMP stimulus), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0050832](http://purl.obolibrary.org/obo/GO_0050832) (defense response to fungus), [GO:1905037](http://purl.obolibrary.org/obo/GO_1905037) (autophagosome organization), [GO:0050728](http://purl.obolibrary.org/obo/GO_0050728) (negative regulation of inflammatory response), [GO:0060351](http://purl.obolibrary.org/obo/GO_0060351) (cartilage development involved in endochondral bone morphogenesis), [GO:0008236](http://purl.obolibrary.org/obo/GO_0008236) (serine-type peptidase activity), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0014070](http://purl.obolibrary.org/obo/GO_0014070) (response to organic cyclic compound), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0061844](http://purl.obolibrary.org/obo/GO_0061844) (antimicrobial humoral immune response mediated by antimicrobial peptide), [GO:0032715](http://purl.obolibrary.org/obo/GO_0032715) (negative regulation of interleukin-6 production), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0001958](http://purl.obolibrary.org/obo/GO_0001958) (endochondral ossification), [GO:0035307](http://purl.obolibrary.org/obo/GO_0035307) (positive regulation of protein dephosphorylation), [GO:0032436](http://purl.obolibrary.org/obo/GO_0032436) (positive regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0010543](http://purl.obolibrary.org/obo/GO_0010543) (regulation of platelet activation), [GO:1903142](http://purl.obolibrary.org/obo/GO_1903142) (positive regulation of establishment of endothelial barrier), [GO:0061474](http://purl.obolibrary.org/obo/GO_0061474) (phagolysosome membrane), [GO:0007191](http://purl.obolibrary.org/obo/GO_0007191) (adenylate cyclase-activating dopamine receptor signaling pathway), [GO:0043407](http://purl.obolibrary.org/obo/GO_0043407) (negative regulation of MAP kinase activity), [GO:0030492](http://purl.obolibrary.org/obo/GO_0030492) (hemoglobin binding), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0046512](http://purl.obolibrary.org/obo/GO_0046512) (sphingosine biosynthetic process), [GO:0002062](http://purl.obolibrary.org/obo/GO_0002062) (chondrocyte differentiation), [GO:0043243](http://purl.obolibrary.org/obo/GO_0043243) (positive regulation of protein complex disassembly), [GO:0046513](http://purl.obolibrary.org/obo/GO_0046513) (ceramide biosynthetic process), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0007596](http://purl.obolibrary.org/obo/GO_0007596) (blood coagulation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0006029](http://purl.obolibrary.org/obo/GO_0006029) (proteoglycan metabolic process), [GO:0007599](http://purl.obolibrary.org/obo/GO_0007599) (hemostasis), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0006665](http://purl.obolibrary.org/obo/GO_0006665) (sphingolipid metabolic process), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0097066](http://purl.obolibrary.org/obo/GO_0097066) (response to thyroid hormone), [GO:0006935](http://purl.obolibrary.org/obo/GO_0006935) (chemotaxis), [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0032268](http://purl.obolibrary.org/obo/GO_0032268) (regulation of cellular protein metabolic process), [GO:0032269](http://purl.obolibrary.org/obo/GO_0032269) (negative regulation of cellular protein metabolic process), [GO:0015886](http://purl.obolibrary.org/obo/GO_0015886) (heme transport), [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding), [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding), [GO:0043537](http://purl.obolibrary.org/obo/GO_0043537) (negative regulation of blood vessel endothelial cell migration), [GO:2001240](http://purl.obolibrary.org/obo/GO_2001240) (negative regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer), [GO:0004252](http://purl.obolibrary.org/obo/GO_0004252) (serine-type endopeptidase activity), [GO:0009268](http://purl.obolibrary.org/obo/GO_0009268) (response to pH), [GO:0005585](http://purl.obolibrary.org/obo/GO_0005585) (collagen type II trimer), [GO:0009267](http://purl.obolibrary.org/obo/GO_0009267) (cellular response to starvation), [GO:0042289](http://purl.obolibrary.org/obo/GO_0042289) (MHC class II protein binding), [GO:0071391](http://purl.obolibrary.org/obo/GO_0071391) (cellular response to estrogen stimulus), [GO:0005344](http://purl.obolibrary.org/obo/GO_0005344) (oxygen carrier activity), [GO:1904925](http://purl.obolibrary.org/obo/GO_1904925) (positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0001894](http://purl.obolibrary.org/obo/GO_0001894) (tissue homeostasis), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0070050](http://purl.obolibrary.org/obo/GO_0070050) (neuron cellular homeostasis), [GO:1901805](http://purl.obolibrary.org/obo/GO_1901805) (beta-glucoside catabolic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding), [GO:2000266](http://purl.obolibrary.org/obo/GO_2000266) (regulation of blood coagulation, intrinsic pathway), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), [GO:0031721](http://purl.obolibrary.org/obo/GO_0031721) (hemoglobin alpha binding), [GO:0031722](http://purl.obolibrary.org/obo/GO_0031722) (hemoglobin beta binding), [GO:0071548](http://purl.obolibrary.org/obo/GO_0071548) (response to dexamethasone), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0030193](http://purl.obolibrary.org/obo/GO_0030193) (regulation of blood coagulation), [GO:0030195](http://purl.obolibrary.org/obo/GO_0030195) (negative regulation of blood coagulation), [GO:0034395](http://purl.obolibrary.org/obo/GO_0034395) (regulation of transcription from RNA polymerase II promoter in response to iron), [GO:0002040](http://purl.obolibrary.org/obo/GO_0002040) (sprouting angiogenesis), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0042730](http://purl.obolibrary.org/obo/GO_0042730) (fibrinolysis), [GO:0005159](http://purl.obolibrary.org/obo/GO_0005159) (insulin-like growth factor receptor binding), [GO:0007605](http://purl.obolibrary.org/obo/GO_0007605) (sensory perception of sound), [GO:0023021](http://purl.obolibrary.org/obo/GO_0023021) (termination of signal transduction), [GO:0007606](http://purl.obolibrary.org/obo/GO_0007606) (sensory perception of chemical stimulus), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0001502](http://purl.obolibrary.org/obo/GO_0001502) (cartilage condensation), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0031838](http://purl.obolibrary.org/obo/GO_0031838) (haptoglobin-hemoglobin complex), [GO:0033334](http://purl.obolibrary.org/obo/GO_0033334) (fin morphogenesis), [GO:0002839](http://purl.obolibrary.org/obo/GO_0002839) (positive regulation of immune response to tumor cell), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0033574](http://purl.obolibrary.org/obo/GO_0033574) (response to testosterone), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0019825](http://purl.obolibrary.org/obo/GO_0019825) (oxygen binding), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:1903052](http://purl.obolibrary.org/obo/GO_1903052) (positive regulation of proteolysis involved in cellular protein catabolic process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0060272](http://purl.obolibrary.org/obo/GO_0060272) (embryonic skeletal joint morphogenesis), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0007584](http://purl.obolibrary.org/obo/GO_0007584) (response to nutrient), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0005201](http://purl.obolibrary.org/obo/GO_0005201) (extracellular matrix structural constituent), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0005833](http://purl.obolibrary.org/obo/GO_0005833) (hemoglobin complex), [GO:0004348](http://purl.obolibrary.org/obo/GO_0004348) (glucosylceramidase activity), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0004866](http://purl.obolibrary.org/obo/GO_0004866) (endopeptidase inhibitor activity), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0050766](http://purl.obolibrary.org/obo/GO_0050766) (positive regulation of phagocytosis), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0033561](http://purl.obolibrary.org/obo/GO_0033561) (regulation of water loss via skin), [GO:0050819](http://purl.obolibrary.org/obo/GO_0050819) (negative regulation of coagulation), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0043202](http://purl.obolibrary.org/obo/GO_0043202) (lysosomal lumen), [GO:0044537](http://purl.obolibrary.org/obo/GO_0044537) (regulation of circulating fibrinogen levels), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0032463](http://purl.obolibrary.org/obo/GO_0032463) (negative regulation of protein homooligomerization), [GO:0071356](http://purl.obolibrary.org/obo/GO_0071356) (cellular response to tumor necrosis factor), [GO:0071599](http://purl.obolibrary.org/obo/GO_0071599) (otic vesicle development), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:1903061](http://purl.obolibrary.org/obo/GO_1903061) (positive regulation of protein lipidation), [GO:0016798](http://purl.obolibrary.org/obo/GO_0016798) (hydrolase activity, acting on glycosyl bonds), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0036268](http://purl.obolibrary.org/obo/GO_0036268) (swimming), [GO:0051918](http://purl.obolibrary.org/obo/GO_0051918) (negative regulation of fibrinolysis), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0060174](http://purl.obolibrary.org/obo/GO_0060174) (limb bud formation), [GO:1901215](http://purl.obolibrary.org/obo/GO_1901215) (negative regulation of neuron death), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0070012](http://purl.obolibrary.org/obo/GO_0070012) (oligopeptidase activity), [GO:0097037](http://purl.obolibrary.org/obo/GO_0097037) (heme export), [GO:2000504](http://purl.obolibrary.org/obo/GO_2000504) (positive regulation of blood vessel remodeling), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0030278](http://purl.obolibrary.org/obo/GO_0030278) (regulation of ossification), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0036019](http://purl.obolibrary.org/obo/GO_0036019) (endolysosome), 

**Class expressions from DL-Learner:**

- Thing 54.87%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.86%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 50.86%
- [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane) 50.86%
- [GO:0005585](http://purl.obolibrary.org/obo/GO_0005585) (collagen type II trimer) 50.86%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.22%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 36.22%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005498](http://purl.obolibrary.org/obo/GO_0005498) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.22%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005490](http://purl.obolibrary.org/obo/GO_0005490) (obsolete cytochrome P450) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.22%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005489](http://purl.obolibrary.org/obo/GO_0005489) (obsolete electron transporter activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.22%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005486](http://purl.obolibrary.org/obo/GO_0005486) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.22%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005485](http://purl.obolibrary.org/obo/GO_0005485) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.22%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005482](http://purl.obolibrary.org/obo/GO_0005482) (obsolete vesicle targeting) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.22%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005481](http://purl.obolibrary.org/obo/GO_0005481) (obsolete vesicle fusion) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.22%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005480](http://purl.obolibrary.org/obo/GO_0005480) (obsolete vesicle transport) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.22%


